Chairman Emeritus Peter C. Farrell - 18 Nov 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Director
Signature
Peter Farrell, Chairman
Issuer symbol
RMD
Transactions as of
18 Nov 2021
Net transactions value
$0
Form type
4
Filing time
22 Nov 2021, 18:45:09 UTC
Previous filing
15 Nov 2021
Next filing
26 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +478 +0.25% $0.000000 192,102 18 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $0 +1,695 $0.000000 1,695 18 Nov 2021 ResMed Common Stock 1,695 $263.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2022, or the annual shareholder's meeting in the year following the grant date.
F2 Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.